Six States Lead SSC Contest

WASHINGTON—Several states began the race to acquire the Superconducting Supercollider (SSC) long before January 30, when the Reagan administration sounded the starting gun by announcing its support for the $4.4 billion project. That early jump may prove decisive. The August deadline for proposals gives an advantage to states that have spent plenty of money deciding where and how to build and operate the collider. Many of those decisions were made at least two years ago, and since then offi

Written byTherese Lloyd
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

The August deadline for proposals gives an advantage to states that have spent plenty of money deciding where and how to build and operate the collider. Many of those decisions were made at least two years ago, and since then officials have mobilized governments, universities and private industry to carry out detailed and expensive site evaluations.

Dozens of states have expressed an interest in the project, and Energy Secretary John Herrington told Senate Energy Committee members two weeks ago that "there is no short list" of contenders. But there is consensus among high-energy physicists that six states—Arizona, California, Colorado, Illinois, Ohio and Texas—come closest to meeting the essential features that the Department has described for the project. Another half-dozen states—Idaho, New Mexico, New York, North Carolina, Utah and Washington—are believed to have some, but not enough, of the "right stuff."

"Our business, ultimately, is to get the best deal for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies